{"transactions":[{"id":680700,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":21449,"kind":"person","name":"Rocca Fortunato R.","position":1,"cik":"0001492734","reported_name":"Rocca Fortunato R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-08-20T21:03:00.000Z","date":"2026-08-20","kind":"grant","planned":false,"acquired":true,"shares":69252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive the economic equivalent of one share of common stock of Interpace Biosciences, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on August 20, 2027, subject to the Reporting Person's continued service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on August 20, 2027, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":69252,"derivative":{"underlying":"Common Stock","underlying_shares":69252},"source":{"system":"sec-edgar","filing":"0001493152-26-039505","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000149315226039505/ownership.xml","form_type":"4"}},{"id":2360529,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":21449,"kind":"person","name":"Rocca Fortunato R.","position":1,"cik":"0001492734","reported_name":"Rocca Fortunato R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-02T21:37:54.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":4322,"price":7.12,"value":30772.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the Reporting Person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted on February 23, 2021."}],"balance_after":120678,"source":{"system":"sec-edgar","filing":"0001274737-22-000016","document":"wf-form4_164625703760601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492734/000127473722000016/wf-form4_164625703760601.xml","form_type":"4"}},{"id":2408335,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":21449,"kind":"person","name":"Rocca Fortunato R.","position":1,"cik":"0001492734","reported_name":"Rocca Fortunato R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-08T21:19:37.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 75,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock unit will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of February 4, 2022, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 75,000 shares of restricted stock units granted on February 4, 2022 and 50,000 shares of restricted stock units granted on February 23, 2021."}],"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001274737-22-000008","document":"wf-form4_164435515279183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492734/000127473722000008/wf-form4_164435515279183.xml","form_type":"4"}},{"id":2832728,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":21449,"kind":"person","name":"Rocca Fortunato R.","position":1,"cik":"0001492734","reported_name":"Rocca Fortunato R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option(right to buy)","published_at":"2021-02-25T22:04:50.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is exercisable as it vests. 25% of the shares subject to the option vest on February 23, 2022, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.  In addition, the stock option may become fully vested upon a qualifying termination of employment in connection with a change in control."}],"balance_after":40000,"derivative":{"exercise_price":18.2,"expiration_date":"2031-02-22","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001274737-21-000008","document":"wf-form4_161429066582208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492734/000127473721000008/wf-form4_161429066582208.xml","form_type":"4"}},{"id":2832727,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":21449,"kind":"person","name":"Rocca Fortunato R.","position":1,"cik":"0001492734","reported_name":"Rocca Fortunato R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-25T22:04:50.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of March 1, 2020, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 50,000 shares of restricted stock units."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001274737-21-000008","document":"wf-form4_161429066582208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492734/000127473721000008/wf-form4_161429066582208.xml","form_type":"4"}},{"id":3085388,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":21449,"kind":"person","name":"Rocca Fortunato R.","position":1,"cik":"0001492734","reported_name":"Rocca Fortunato R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-10T23:59:49.000Z","date":"2020-07-09","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is eligible to vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":28000,"derivative":{"exercise_price":5.21,"expiration_date":"2030-07-08","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001493152-20-013114","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000149315220013114/ownership.xml","form_type":"4"}},{"id":3314495,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":21449,"kind":"person","name":"Rocca Fortunato R.","position":1,"cik":"0001492734","reported_name":"Rocca Fortunato R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option(right to buy)","published_at":"2020-01-09T22:09:38.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":155000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable as it vests. 25% of the shares subject to the option vest on January 1, 2021, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":155000,"derivative":{"exercise_price":24.19,"expiration_date":"2030-01-08","underlying":"Stock Option(right to buy)","underlying_shares":155000},"source":{"system":"sec-edgar","filing":"0001274737-20-000013","document":"wf-form4_157860776060573.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492734/000127473720000013/wf-form4_157860776060573.xml","form_type":"4"}},{"id":3408948,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":21449,"kind":"person","name":"Rocca Fortunato R.","position":1,"cik":"0001492734","reported_name":"Rocca Fortunato R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option(right to buy)","published_at":"2019-09-20T23:01:59.000Z","date":"2019-09-18","kind":"grant","acquired":true,"shares":138659,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable as it vests. 25% of the shares subject to the option vest on September 18, 2020, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":138659,"derivative":{"exercise_price":14,"expiration_date":"2029-09-17","underlying":"Common Stock","underlying_shares":138659},"source":{"system":"sec-edgar","filing":"0000899243-19-024019","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492734/000089924319024019/doc4.xml","form_type":"4"}}]}